Metagenomi Therapeutics, Inc. Common Stock (MGX)
Metagenomi Therapeutics, Inc. Common Stock (MGX) has reported earnings 10 times since Mar 27, 2024. The stock moves an average of ±6.24% the day after reporting, closing higher 30.0% of the time. Its largest post-earnings gain was +3.83% (May 14, 2024) and its largest decline was -15.07% (Nov 12, 2025). The next earnings report is predicted for 2026-08-13 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±6.24%
Positive %
30.0%
Negative %
70.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 11, 2026 | ☽ POST | $1.38 | $1.40 | $1.35 | 24,549 | +0.37% | open_in_new |
| Mar 05, 2026 | ☽ POST | $1.54 | $1.68 | $1.60 | 13,694 | -7.19% | open_in_new |
| Nov 12, 2025 | ☀ PRE | $1.99 | $2.00 | $1.86 | 28,066 | -15.07% | open_in_new |
| Aug 12, 2025 | ☽ POST | $1.82 | $1.88 | $1.87 | 6,724 | +3.74% | open_in_new |
| May 13, 2025 | ☽ POST | $1.58 | $1.60 | $1.60 | 19,763 | -6.25% | open_in_new |
| Mar 17, 2025 | ☽ POST | $2.00 | $2.00 | $1.88 | 20,091 | -8.51% | open_in_new |
| Nov 13, 2024 | ☽ POST | $2.20 | $2.23 | $2.11 | 24,848 | -11.37% | open_in_new |
| Aug 14, 2024 | ☀ PRE | $3.37 | $3.37 | $3.11 | 12,439 | -4.31% | open_in_new |
| May 14, 2024 | ☽ POST | $6.66 | $6.66 | $6.53 | 2,032 | +3.83% | open_in_new |
| Mar 27, 2024 | ☀ PRE | $11.26 | $11.67 | $11.05 | 2,815 | -1.78% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±6.24%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
4 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 4 | 20260610 | open_in_new SEC.gov |
| 8-K | 20260610 | open_in_new SEC.gov |
Frequently asked about MGX earnings
When does Metagenomi Therapeutics, Inc. Common Stock report earnings next? expand_more
Metagenomi Therapeutics, Inc. Common Stock (MGX)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MGX stock move after earnings? expand_more
Over 10 reports, MGX has moved an average of ±6.24% the session after earnings, closing higher 30.0% of the time.
What was MGX's biggest post-earnings move? expand_more
MGX's largest post-earnings gain on record was +3.83% on May 14, 2024, and its largest decline was -15.07% on Nov 12, 2025.
Where can I find Metagenomi Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Metagenomi Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right